Photo from Unsplash
Originally Posted On: https://bluefinvision.com/blog/the-myth-of-the-free-refractive-consultation/
What patients are not told – and what they should ask
“A refractive consultation cannot be both free and clinically complete.”
Mr Mfazo Hove, Consultant Ophthalmic Surgeon
“Free consultation” is one of the most effective phrases in private healthcare marketing. It reduces friction, increases enquiries, and creates the impression of accessibility. But in refractive surgery, it raises a clinical question that patients rarely think to ask.
If a consultation genuinely costs nothing to deliver, what does that say about what is being delivered?
Below, we address the economic, clinical, and ethical realities behind the model.
Section 1: The Economics
Q. What does a refractive consultation actually cost to deliver?
More than most patients realise. At Blue Fin Vision®, a full consultation pathway comprises:
|
Component
|
Cost
|
|---|---|
|
New patient surgical consultation (45 minutes)
|
£500
|
|
OCT – macula and optic nerve
|
£200
|
|
Corneal topography
|
£200
|
|
Biometry
|
£200
|
|
Endothelial cell count (ECC)
|
£150
|
|
True cost of consultation pathway
|
£1,250
|
|
Blue Fin Vision® consultation fee
|
£500
|
Blue Fin Vision® Answer
Our £500 consultation fee is for new surgical patients and includes 45 minutes of protected surgeon time. A 30-minute consultation is available at £325 for straightforward follow-up and non-surgical discussions. Neither figure represents a premium. Both represent a subsidised pathway, by design. The diagnostics exist to protect clinical decision-making, not to generate revenue.
A 45-minute new surgical patient consultation alone is £500.
The full diagnostic pathway brings the real cost to £1,250.
Our fee is £500.
That is not premium. That is subsidised.
Q. So how do clinics offer it for free?
There are three possibilities. Any one of them, or a combination, applies in practice:
- The consultation is not equivalent in depth, time, or clinical seniority
- The cost is recovered in surgical pricing, financing margins, or add-ons
- The consultation is structured as a conversion process, not a clinical one
A useful comparison: if a café offered free coffee, you would reasonably ask how. The question is just as valid in medicine.
Q. Why does that distinction matter?
Because the consultation determines the outcome as much as the surgery itself.
Patients who enter surgery with incomplete information about their risks, realistic outcomes, or alternatives are not better served by having paid less for the consultation. They are worse served.
Section 2: What Gets Left Out
Q. How do clinics reduce the cost of a “free” consultation?
Primarily by omitting diagnostics.
The full diagnostic pathway for a safe refractive assessment includes OCT, corneal topography, biometry, and endothelial cell count (ECC). Each has a specific clinical purpose. None is optional in a thorough evaluation. But each one costs money to perform.
A clinic offering a free or heavily subsidised consultation has to reduce cost somewhere. The most straightforward place to do that is diagnostics. The patient does not see the line items. They do not know what a full pathway looks like, and they are not told what has been left out.
Q. Why does the endothelial cell count matter?
The ECC assesses the health of the corneal endothelium, the inner cell layer responsible for keeping the cornea clear. These cells do not regenerate. Once lost, they are gone.
In the context of refractive surgery, particularly ICL implantation and lens replacement surgery, the ECC is clinically significant. A patient with low cell density may face accelerated endothelial loss following surgery, with long-term implications for corneal clarity and vision quality. Without an ECC, that risk cannot be assessed, let alone discussed.
It is not a premium test. It is a standard safety check. Its omission is not a minor gap.
Q. Are patients told when tests have been omitted?
Rarely. That is the core of the problem.
A clinic that omits diagnostics does not typically present this as a choice. It is not framed as: “We are not including an ECC today – would you like to add it for £150?” The patient does not know the test exists, does not know it is absent, and cannot make an informed decision about whether to proceed without it.
This is a transparency failure. Not necessarily a deliberate one, but a structural one. The patient does not know what they do not know.
Q. Can patients obtain their diagnostic results and take them elsewhere?
They should be able to. In practice, this is inconsistently handled.
Patients have a legal right to their medical records under UK GDPR, including diagnostic imaging and scan data. But not every clinic routinely provides these. Topography maps, OCT reports, biometry printouts, and ECC data are not always shared with patients as a matter of course.
The consequence is significant. If diagnostic data is held by the clinic and not shared, a patient cannot seek a second opinion without formally requesting it, often after a decision to proceed has already been made. And if the data does not exist because the test was never performed, there is nothing to share.
Blue Fin Vision® Answer
At Blue Fin Vision®, all diagnostic results are provided to patients as a matter of course, not on request. Topography maps, OCT reports, biometry data, and ECC results belong to the patient. They are free to seek a second opinion with their full results. That is not a risk to us. It is a standard we hold ourselves to.
Q. What should I specifically ask about diagnostics before booking?
Ask four questions directly:
- Which diagnostic tests are included in my consultation, specifically?
- Is an endothelial cell count performed as standard?
- Will I receive copies of all my results to keep?
- If I want a second opinion, will my full diagnostic data be released to me?
If any of those questions produces hesitation, that hesitation is informative.
Section 3: The Clinical Reality
Q. Can a shorter or optometrist-led consultation reach the same standard?
Not for complex refractive decisions, no.
Optometrists are highly skilled clinicians. But the legal and clinical responsibility for surgical consent, risk management, and intraoperative decision-making rests with the operating surgeon. A screening process led by a non-surgeon is not the same as a surgical consultation.
This is not a criticism of optometrists. It is a recognition that surgical consent and risk modelling sit with the operating surgeon, and that no delegation of that responsibility, however well-intentioned, changes what the patient is legally and clinically owed.
The distinction matters most in edge cases, and in refractive surgery, edge cases are common:
Example 1: Moderate to high myopia (e.g. −6.00D)
- Baseline retinal detachment risk is elevated in high myopia
- Lens surgery further increases that risk
- Posterior capsule rupture, if it occurs, significantly amplifies it¹
- This three-way interaction requires individual risk modelling, not a screening protocol
Example 2: Older patient considering spectacle independence
- Laser enhancement on an older cornea carries different risk-benefit parameters
- Secondary lens implantation (e.g. Sulcoflex®) may be an alternative²
- Dual-optic systems require specific discussion of optical trade-offs
- None of these conversations fit a standardised script
Q. What is the legal standard for consent?
Following Montgomery v Lanarkshire Health Board , the legal standard for consent in the UK requires:
- Disclosure of material risks, defined by what this patient would consider significant
- Tailored discussion of alternatives, not just the proposed procedure
- Genuine patient understanding, not simply a signed form
Blue Fin Vision® Answer
This standard is not compatible with a high-throughput screening consultation. Consent is a clinical process. The time allocated to the consultation is where that process lives or fails.
Q. What are the documented clinical consequences of inadequate consultation?
The evidence is consistent:
- Retinal detachment risk increases materially after lens surgery in myopic patients³
- Posterior capsule rupture significantly elevates downstream complication risk⁴
- Patient dissatisfaction following cataract and refractive surgery is most strongly associated with unmet expectations⁵, not surgical error
The last point is important. Most complaints in refractive surgery do not arise from surgical failure. They arise from a gap between what the patient expected and what was realistically achievable. That gap is created, or closed, in the consultation.
Section 4: The Structural Problem
Q. Why does the “free consultation” model create pressure on patients?
Because the business model requires it to.
A clinic offering free consultations carries the same fixed costs as any other: staff, facilities, diagnostic equipment, surgeon fees, regulatory compliance. If consultations generate no revenue, those costs must be recovered elsewhere, most directly, through surgical procedures.
This creates a structural pressure that operates independently of the intentions of any individual clinician. It builds within the system and emerges as:
- Higher conversion rate targets
- Standardised consultation scripts that reduce nuance
- Incentivised recommendations, explicit or implicit
- Framing of decisions around price rather than suitability
The question is not whether the clinician involved is well-intentioned. Most are. The question is whether the system they are operating in is structured to serve the patient first.
Consider the arithmetic directly: if a clinic runs two full days of free consultations and no patients proceed to surgery, the business still carries the cost of every hour, every scan, every member of staff. That pressure does not disappear. It moves – into targets, into scripts, into the room where the patient is sitting.
Q. Does Blue Fin Vision® benefit from charging for consultations?
Yes. And that is precisely the point.
We are not pretending that our consultations are free, or that they cost us nothing to deliver. The honest position is this: at £500 for a 45-minute new patient consultation, we are not making a significant margin. We are also not losing money. The fee covers the surgeon’s time, the diagnostic pathway, and the infrastructure required to deliver it properly.
That is a deliberate design choice.
At zero cost, the pressure to convert every consultation into a surgical case becomes structural, not theoretical. The business cannot survive otherwise. Consultations become a cost centre that must justify itself through surgical revenue. That changes everything: how long the consultation runs, how risks are framed, how alternatives are discussed, whether the patient who is not yet ready, or should not proceed, is told so plainly.
At £500, non-refundable, we are financially indifferent to whether a patient proceeds to surgery or not. That is not a marketing claim. It is an arithmetic one. The consultation has been paid for. It has value independent of what follows. If the right clinical answer is “not yet” or “not you”, we can say that without it costing us anything.
That is what financial neutrality at the point of consultation actually means. And it is the only structural arrangement in which a genuinely independent clinical recommendation is possible.
Blue Fin Vision® Answer
We charge because the consultation has genuine clinical value, and because a zero-cost consultation creates a financial dependency on conversion that we are not willing to accept. The £500 fee is not profit. It is independence.
Q. Does Blue Fin Vision® offer any complimentary consultations?
Yes. Blue Fin Vision® offers complimentary consultations for laser eye surgery, where the initial assessment is a suitability screening rather than a full surgical consultation. The distinction is important. A laser suitability assessment determines whether a patient’s cornea, prescription, and visual demands are appropriate for treatment. It does not involve the same depth of surgical risk modelling, consent discussion, or diagnostic pathway required for procedures such as ICL implantation, refractive lens exchange, or cataract surgery.
For those more complex surgical pathways, the £500 paid consultation exists precisely because the clinical decision-making is more involved, the diagnostic requirements are greater, and the consequences of incomplete assessment are more significant. The complimentary laser consultation and the paid surgical consultation are not the same service delivered at different price points. They are different services, structured to reflect the clinical demands of each pathway.
Q. Why do you require the £500 to be paid upfront to secure a consultation?
Because it selects for the right patient.
The £500 consultation fee is payable at the point of booking. It is non-refundable. That is a deliberate policy, and it serves a clinical purpose.
Patients for whom cost is the primary driver of their decision, above safety, above clinical quality, above surgeon experience, are not patients we are best placed to serve. That is not a value judgement about those patients. It is an honest acknowledgement that what we offer is not optimised for price competition, and that trying to be all things to all patients produces worse outcomes for everyone.
The upfront fee does something else too. It means the patients who sit across from us in consultation have already made a considered commitment. They are not browsing. They are not here because the entry cost was zero. They have invested in the process, which means they are more likely to engage with it seriously, to ask the right questions, to weigh the information, to make a decision that reflects their actual priorities.
A free consultation attracts everyone. That sounds like an advantage. In a clinical setting, it is not always one.
Blue Fin Vision® Answer
We are not the right practice for every patient. We are the right practice for patients who have decided that clinical standard, surgeon transparency, and outcome quality matter more than cost. The £500 upfront fee is how both parties establish that alignment before anyone walks through the door.
Q. How does pricing interact with clinical decision-making?
When surgical decisions become price-driven, the wrong question gets asked.
Patients stop asking: “What is the safest option for my anatomy and lifestyle?”
And start asking: “What is the cheapest option available?”
Price matching, promotional discounts, and time-limited offers are incompatible with the standard of clinical independence that refractive surgery requires. They serve the business model, not the patient.
Blue Fin Vision® Answer
Blue Fin Vision® operates fixed, transparent pricing with no discounts and no negotiation. This is not a commercial position. It is a clinical one. Financial independence is what makes clinical independence possible.
Q. Does the same cost-cutting logic apply to the choice of lens?
Yes. And this is where the opacity is hardest to detect.
Many clinics describe their lens options in their marketing as “premium lenses” or “advanced technology lenses.” The language is reassuring. It implies quality. But it does not tell you which lens will be implanted in your eye, who manufactures it, what the independent published evidence base looks like, or how the surgeon has chosen it for your specific anatomy.
Lens selection is not a commodity decision. In cataract surgery and refractive lens exchange, the implanted lens is permanent. The optical characteristics, the material, the edge design, the dysphotopsia profile, and the long-term stability of that lens all matter, and they vary significantly between manufacturers and models.
A clinic that has negotiated preferential pricing with a lens manufacturer, or that selects lenses on the basis of margin rather than clinical fit, has a financial incentive that runs directly counter to the patient’s interest. That incentive is invisible to the patient unless they know to ask.
At Blue Fin Vision®, the lens implanted in new lens replacement and cataract patients is the ZEISS AT LISA tri 839MP trifocal IOL. That is not a category. It is a specific lens, from a specific manufacturer, with a specific evidence base. Mr Hove has the same lens implanted in his own eyes. The choice is named, explained, and justified, not hidden behind generic language.
Blue Fin Vision® Answer
Ask any clinic you are considering: which specific lens will you implant, who makes it, and why have you chosen it for me? If the answer is vague, that vagueness is doing work. A surgeon who is confident in their lens choice, and whose recommendation is not influenced by margin, will answer that question without hesitation.
Section 5: What Patients Should Ask
Q. What questions should I ask before booking a refractive consultation?
Five questions. All of them matter.
|
Question
|
Why it matters
|
|---|---|
|
Who will be conducting my consultation?
|
Optometrist-led screening and consultant surgeon-led consultation are not equivalent for complex surgical decisions.
|
|
What diagnostics are included, and who interprets them?
|
OCT, topography, and biometry are not optional in a safe refractive pathway. Interpretation by the operating surgeon is what makes them useful.
|
|
How much time is allocated to the consultation?
|
At Blue Fin Vision®, new surgical patient consultations are 45 minutes as standard. 20 minutes is a screening slot.
|
|
Will my personal risks be explained in detail?
|
Generic risk statistics are not consent. Your anatomy, lifestyle, and expectations require individual discussion.
|
|
Is this a clinical consultation or a conversion process?
|
The honest answer to this question, if you could get one, tells you everything.
|
Quick Reference: Common Questions
Is a free refractive consultation safe?
A free consultation may be clinically adequate, but patients should establish three things before proceeding: who performs it (optometrist or consultant surgeon), which diagnostics are included, and whether all results will be provided to them directly. Without those answers, the consultation cannot be properly evaluated.
Why do some clinics charge for refractive consultations?
Charging for a consultation creates financial independence from surgical conversion. When the consultation fee covers its own cost, the surgeon has no financial incentive to recommend surgery. That structural neutrality is what makes an unbiased clinical recommendation possible.
What diagnostics should be included in a refractive consultation?
A complete refractive assessment should include: OCT of the macula and optic nerve, corneal topography, biometry, and endothelial cell count (ECC). Each addresses a distinct clinical question. A pathway that omits any of these without explanation is not a full assessment.
What is the difference between a refractive screening and a refractive consultation?
A screening determines whether a patient is broadly suitable for a procedure. A consultation determines what is specifically right for this patient, including full risk discussion, exploration of alternatives, and surgical consent delivered in line with the Montgomery standard. The two are not interchangeable, regardless of what they are called.
How do I know which lens will be implanted in my eye?
Ask directly. The answer should name a specific lens and manufacturer, not a category. If the response refers to ‘premium lenses’ or ‘advanced technology’ without naming the product, follow up. The lens implanted in your eye is permanent. You are entitled to know exactly what it is.
Conclusion
A free consultation does not eliminate cost. It moves it – into the surgical fee, into the system, or into the decision-making process itself.
In medicine, hidden cost creates hidden bias. The consultation is not a preliminary step before the clinical process begins. It is where the clinical process begins.
Patients deserve to understand that distinction before they book.
That is what the consultation fee is for. Not profit. Clarity.
References
- Erie JC, Raecker ME, Baratz KH, Schleck CD, Burke JP. Risk of retinal detachment after cataract extraction. Ophthalmology. 2006;113(11):2026-2032.
- Auffarth GU, Rabsilber TM, Horn FK. Secondary intraocular lens implantation: indications and outcomes. Ophthalmologe. 2012;109(1):13-20.
- Daien V, Le Pape A, Heve D, Carriere I, Villain M. Incidence and characteristics of retinal detachment after cataract surgery. Ophthalmology. 2015;122(12):2360-2367.
- Day AC, Donachie PHJ, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 1. Eye. 2015;29(4):552-560.
- Lundström M, Dickman M, Henry Y, Manning S, Rosen P, Tassignon MJ. Risk factors for dissatisfaction after cataract surgery. J Cataract Refract Surg. 2015;41(9):1995-2003.
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Hove is a consultant ophthalmic surgeon who has performed more than 57,000 procedures. His training includes 6.5 years of specialist development at Moorfields Eye Hospital, followed by five years as a consultant at the Western Eye Hospital (Imperial College Healthcare NHS Trust). He is a consultant at Blue Fin Vision®, an elite ophthalmology clinic serving London, Essex and Hertfordshire, working alongside an experienced clinical team delivering comprehensive ophthalmic care. He specialises in cataract surgery and advanced vision correction, including laser procedures, lens replacement and implantable Collamer lenses (ICL).
Schedule Your Consultation Today
Blue Fin Vision® has been awarded the Doctify Outstanding Patient Experience Award for three consecutive years, 2024, 2025, and 2026, independently verified across all patient reviews.
To discuss your options or book a consultation with Mr Hove’s consultant-led team, contact Blue Fin Vision® across our London, Hertfordshire, and Essex locations.
You can also explore our consultation philosophy, pricing structure, and published outcome data at bluefinvision.com/consultation-philosophy.
